Literature DB >> 18059340

Interaction with PI3-kinase contributes to the cytotoxic activity of apoptin.

S Maddika1, E Wiechec, S R Ande, I K Poon, U Fischer, S Wesselborg, D A Jans, K Schulze-Osthoff, M Los.   

Abstract

Apoptin, a small protein from the chicken anemia virus, has attracted attention because of its specificity in killing tumor cells. Localization of apoptin in the nucleus of tumor cells has been shown to be vital for proapoptotic activity, however, targeted expression of apoptin in the nucleus of normal cells does not harm the cells, indicating that nuclear localization of apoptin is insufficient for its cytotoxicity. Here, we demonstrate for the first time that apoptin interacts with the SH3 domain of p85, the regulatory subunit of phosphoinositide 3-kinase (PI3-K), through its proline-rich region. Apoptin derivatives devoid of this proline-rich region do not interact with p85, are unable to activate PI3-K, and show impaired apoptosis induction. Moreover, apoptin mutants containing the proline-rich domain are sufficient to elevate PI3-K activity and to induce apoptosis in cancer cells. Downregulation of p85 leads to nuclear exclusion of apoptin and impairs cell death induction, indicating that interaction with the p85 PI3-K subunit essentially contributes to the cytotoxic activity of apoptin.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18059340      PMCID: PMC2954967          DOI: 10.1038/sj.onc.1210958

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  19 in total

Review 1.  Signaling by distinct classes of phosphoinositide 3-kinases.

Authors:  B Vanhaesebroeck; M D Waterfield
Journal:  Exp Cell Res       Date:  1999-11-25       Impact factor: 3.905

Review 2.  Tumor-specific nuclear targeting: promises for anti-cancer therapy?

Authors:  Gualtiero Alvisi; Ivan K H Poon; David A Jans
Journal:  Drug Resist Updat       Date:  2006-04-18       Impact factor: 18.500

3.  Cancer-specific toxicity of apoptin is independent of death receptors but involves the loss of mitochondrial membrane potential and the release of mitochondrial cell-death mediators by a Nur77-dependent pathway.

Authors:  Subbareddy Maddika; Evan P Booy; Dina Johar; Spencer B Gibson; Saeid Ghavami; Marek Los
Journal:  J Cell Sci       Date:  2005-10-01       Impact factor: 5.285

4.  Apoptin-induced cell death is modulated by Bcl-2 family members and is Apaf-1 dependent.

Authors:  M Burek; S Maddika; C J Burek; P T Daniel; K Schulze-Osthoff; M Los
Journal:  Oncogene       Date:  2006-04-06       Impact factor: 9.867

Review 5.  The nuclear phosphoinositide 3-kinase/AKT pathway: a new second messenger system.

Authors:  Luca M Neri; Paola Borgatti; Silvano Capitani; Alberto M Martelli
Journal:  Biochim Biophys Acta       Date:  2002-10-10

6.  Involvement of phosphatidylinositol 3-kinase in NFAT activation in T cells.

Authors:  T Jascur; J Gilman; T Mustelin
Journal:  J Biol Chem       Date:  1997-05-30       Impact factor: 5.157

7.  Apoptin is modified by SUMO conjugation and targeted to promyelocytic leukemia protein nuclear bodies.

Authors:  K Janssen; T G Hofmann; D A Jans; R T Hay; K Schulze-Osthoff; U Fischer
Journal:  Oncogene       Date:  2006-08-21       Impact factor: 9.867

8.  Apoptin nuclear accumulation is modulated by a CRM1-recognized nuclear export signal that is active in normal but not in tumor cells.

Authors:  Ivan K H Poon; Cristina Oro; Manisha M Dias; Jingpu Zhang; David A Jans
Journal:  Cancer Res       Date:  2005-08-15       Impact factor: 12.701

9.  Akt is transferred to the nucleus of cells treated with apoptin, and it participates in apoptin-induced cell death.

Authors:  S Maddika; G H Bay; T J Kroczak; S R Ande; S Maddika; E Wiechec; S B Gibson; M Los
Journal:  Cell Prolif       Date:  2007-12       Impact factor: 6.831

Review 10.  Phosphoinositide kinases.

Authors:  D A Fruman; R E Meyers; L C Cantley
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

View more
  16 in total

Review 1.  Mechanisms of Apoptin-induced cell death.

Authors:  Suna Zhou; Mingxin Zhang; Jia Zhang; Hui Shen; Ermek Tangsakar; Jiansheng Wang
Journal:  Med Oncol       Date:  2011-11-22       Impact factor: 3.064

2.  S100A8/A9 induces autophagy and apoptosis via ROS-mediated cross-talk between mitochondria and lysosomes that involves BNIP3.

Authors:  Saeid Ghavami; Mehdi Eshragi; Sudharsana R Ande; Walter J Chazin; Thomas Klonisch; Andrew J Halayko; Karol D McNeill; Mohammad Hashemi; Claus Kerkhoff; Marek Los
Journal:  Cell Res       Date:  2009-11-24       Impact factor: 25.617

3.  Secretory Transactivating Transcription-apoptin fusion protein induces apoptosis in hepatocellular carcinoma HepG2 cells.

Authors:  Su-Xia Han; Jin-Lu Ma; Yi Lv; Chen Huang; Hai-Hua Liang; Kang-Min Duan
Journal:  World J Gastroenterol       Date:  2008-06-21       Impact factor: 5.742

4.  Unscheduled Akt-triggered activation of cyclin-dependent kinase 2 as a key effector mechanism of apoptin's anticancer toxicity.

Authors:  Subbareddy Maddika; Soumya Panigrahi; Emilia Wiechec; Sebastian Wesselborg; Ute Fischer; Klaus Schulze-Osthoff; Marek Los
Journal:  Mol Cell Biol       Date:  2008-12-22       Impact factor: 4.272

Review 5.  Cancer stem cells as targets for cancer therapy: selected cancers as examples.

Authors:  Sabine Hombach-Klonisch; Ted Paranjothy; Emilia Wiechec; Paola Pocar; Tarek Mustafa; Anja Seifert; Christian Zahl; Klaus Luis Gerlach; Katharina Biermann; Klaus Steger; Cuong Hoang-Vu; Klaus Schulze-Osthoff; Marek Los
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2008-05-30       Impact factor: 4.291

6.  Network-level effects of kinase inhibitors modulate TNF-α-induced apoptosis in the intestinal epithelium.

Authors:  Jessica J Gierut; Levi B Wood; Ken S Lau; Yi-Jang Lin; Casie Genetti; Ahmed A Samatar; Douglas A Lauffenburger; Kevin M Haigis
Journal:  Sci Signal       Date:  2015-12-15       Impact factor: 8.192

7.  Modeling of molecular interaction between apoptin, BCR-Abl and CrkL--an alternative approach to conventional rational drug design.

Authors:  Soumya Panigrahi; Jörg Stetefeld; Jaganmohan R Jangamreddy; Soma Mandal; Sanat K Mandal; Marek Los
Journal:  PLoS One       Date:  2012-01-10       Impact factor: 3.240

8.  Targeting Gene-Viro-Therapy with AFP driving Apoptin gene shows potent antitumor effect in hepatocarcinoma.

Authors:  Kang-Jian Zhang; Jing Qian; Shi-Bing Wang; Yi Yang
Journal:  J Biomed Sci       Date:  2012-02-09       Impact factor: 8.410

Review 9.  Viral genes as oncolytic agents for cancer therapy.

Authors:  Shishir Kumar Gupta; Ravi Kumar Gandham; A P Sahoo; A K Tiwari
Journal:  Cell Mol Life Sci       Date:  2014-11-19       Impact factor: 9.207

10.  Akt and mTOR mediate programmed necrosis in neurons.

Authors:  Q Liu; J Qiu; M Liang; J Golinski; K van Leyen; J E Jung; Z You; E H Lo; A Degterev; M J Whalen
Journal:  Cell Death Dis       Date:  2014-02-27       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.